The Netherlands: Forbion announces first close of Growth Opportunities Fund II

Forbion, a leading European life sciences venture capital firm, has announced the first close of its Forbion Growth Opportunities Fund II at €470m (US$503.5m) exceeding its €450m target. This new fund has attracted several new institutional investors, including pension funds PME and PMT, the Ewing Marion Kauffman Foundation and Reggeborgh, which join returning investors Pantheon,…

You must be a HMI Subscriber to view this content.

Subscribe Now »